IGF-I is a hormone that mediates the effects of growth hormone, playing a key role in growth and cell repair.
IGF-I is often considered in the context of tiredness, reduced capacity, brain fog, or chronic exhaustion. This short overview clarifies what the marker can contribute, where its limits are, and when symptom or illness context becomes more important.
IGF-I is commonly relevant when fatigue raises questions about iron status, storage depletion, or anemia-related complaints. It can provide an important clue, but it rarely explains the full symptom picture by itself.
IGF-I does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
Insulin-like Growth Factor I (IGF-I) is a hormone primarily produced in the liver in response to growth hormone (GH) stimulation. It plays a central role in promoting the growth of bones, muscles, and other tissues throughout life. IGF-I levels reflect the body's growth hormone activity and are essential for normal development and metabolic function. Measuring IGF-I is useful for evaluating growth disorders, monitoring GH therapy, and assessing pituitary function. Because levels change with age and sex, interpretation requires age-adjusted reference ranges.
A low IGF-I value may suggest growth hormone deficiency, inadequate nutrition, liver disease, or certain genetic conditions affecting growth. In children, a low level can be associated with short stature and delayed development. Values below the lab-specific age-adjusted reference range (for example, less than 100 ng/mL or 13 nmol/L in many adults) may warrant further evaluation.
An elevated IGF-I level may indicate excess growth hormone production, as seen in acromegaly or gigantism. It can also occur during pregnancy, puberty, or with certain tumors. A value above the lab's age-adjusted reference range (for example, greater than 300 ng/mL or 39 nmol/L in adults) often prompts additional testing to determine the cause.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
IGF-I is commonly relevant when fatigue raises questions about iron status, storage depletion, or anemia-related complaints. It can provide an important clue, but it rarely explains the full symptom picture by itself.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Insulin-like Growth Factor I (IGF-I) alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
Normal IGF-I levels depend on age and sex. For adults, a typical reference range is approximately 100–300 ng/mL (13–39 nmol/L), but ranges vary between laboratories. Your healthcare provider will interpret your result using the age-appropriate range from the testing lab.
A low IGF-I may suggest growth hormone deficiency, poor nutrition, liver disease, or a condition that impairs growth hormone action. In children, it can be associated with growth failure, while in adults it may contribute to reduced muscle mass and energy.
Yes, high IGF-I levels can indicate acromegaly or gigantism, which are caused by excessive growth hormone. Temporary elevations occur during puberty and pregnancy. Further testing, such as growth hormone suppression tests, is usually needed for a diagnosis.
IGF-I does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
For many fatigue-related, inflammatory, hormonal, or recovery-linked markers, interpretation becomes stronger when symptoms, exertion response, and daily function are considered together.
IGF-I is rarely meaningful in isolation when fatigue, brain fog, or unstable capacity are central. The fatigue hub provides the broader lab-and-symptom context.
Markers linked to sleep, stress, recovery, hormones, or metabolism often become more useful when viewed through pacing and daily load management.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
These references support the information presented on this page.
https://www.gesundheit.gv.at/labor/laborwerte/hormone-tumormarker/igf-1.html
gesundheit.gv.at
https://www.netdoktor.de/krankheiten/wachstumshormonmangel/
netdoktor.de
https://www.msdmanuals.com/de/profi/p%C3%A4diatrie/endokrine-st%C3%B6rungen-bei-kindern/wachstumshormonmangel-bei-kindern
msdmanuals.com
https://flexikon.doccheck.com/de/Insulin-like_growth_factor_1
flexikon.doccheck.com
https://www.pezz.ch/fuer-aerzte/rechner-igf-1/
pezz.ch
https://medlineplus.gov/lab-tests/igf-1-insulin-like-growth-factor-1-test/
medlineplus.gov
https://epub.ub.uni-greifswald.de/files/1982/Dissertation_Lohr_Johannes.pdf
epub.ub.uni-greifswald.de
https://de.wikipedia.org/wiki/Insulin%C3%A4hnliche_Wachstumsfaktoren
de.wikipedia.org
https://epub.ub.uni-greifswald.de/files/1800/diss_niemann_inga.pdf
epub.ub.uni-greifswald.de
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
